Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
about
Neuroinflammation and psychiatric illnessMutant mouse models: genotype-phenotype relationships to negative symptoms in schizophreniaA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesStress-induced deficits in cognition and emotionality: a role of glutamateThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingDendritic spine pathology in schizophreniaAssessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophreniaDopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophreniaLocalization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic studyIncreased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophreniaAbnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophreniaThe importance of the excitatory amino acid transporter 3 (EAAT3)Decreased EAAT2 protein expression in the essential tremor cerebellar cortex.Evolutionarily conserved pattern of AMPA receptor subunit glycosylation in Mammalian frontal cortex.The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophreniaRETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons?Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia.Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1)Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.Regional decoupling of N-acetyl-aspartate and glutamate in schizophreniaMultimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophreniaAcute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.Regional differences in expression of β-tubulin isoforms in schizophrenia.The first decade and beyond of transcriptional profiling in schizophrenia.Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease.Translational potential of astrocytes in brain disorders.Tonic and phasic release of glutamate and acetylcholine neurotransmission in sub-regions of the rat prefrontal cortex using enzyme-based microelectrode arrays.The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders.Update on the neurobiology of schizophrenia: a role for extracellular microdomains.Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.Astroglia, Glutamatergic Transmission and Psychiatric Diseases.GRIN3B missense mutation as an inherited risk factor for schizophrenia: whole-exome sequencing in a family with a familiar history of psychotic disorders.
P2860
Q21245244-62BDD728-0D37-4F3A-8D8A-A070D1EBCE4EQ24632939-C488ACDB-3CD1-4BF8-AB4C-2954EB27A198Q26786354-F5E0BC08-54E3-43DA-8278-E68B9E9D9CCFQ26825021-C486B8FD-5BFC-47C5-B960-31FF1F8C6F5BQ26864995-67329B10-3B2C-41AC-8C6E-318D310D21B0Q26991935-76AE5652-6783-408C-9783-C7DD84CD77DDQ30465586-4705216D-ADA8-4F74-BE1B-4EB71ABC31C5Q33653459-376A6F7D-C43A-48B0-9F17-8818D56832DDQ33786459-2CE69B19-E7EB-415E-8152-9A4ECE71BD97Q33804875-7E980AC7-5A12-49F7-BC9B-65C31635CB1FQ34184026-2D7E9D07-16ED-4156-80DF-A2BFA5722CB3Q34254863-8843D737-E5A7-4AB0-BDDB-32990C6A4D7FQ34331035-15CA58B1-5CDB-4E6F-93D8-40861A4E4F21Q34406087-77C89EB4-0C06-48E1-B7B2-09F36F79545CQ34528594-0B91EEDF-D494-4506-98B2-19B1635300B7Q34551549-32217C70-BC03-4863-B718-2FBCE881152FQ35142747-8F1AD872-359E-4FB4-AA15-324163F9934BQ35186635-99298B63-FA67-4137-AC25-9FA3A43D70F9Q35657864-7883896C-7021-4C37-9C31-248E82ECC5F3Q35662070-95AD2357-8C4A-4F7B-9865-CE42F659FE39Q35760215-8EF511A0-C662-488D-9D48-062128573DBFQ35791075-52B9FA4A-E52C-4140-9526-FCFAAC402F20Q35907263-46DBCDF0-5EA2-46E8-9D71-6E1BF20A99A8Q35953115-BF93DCD8-87CA-473A-B66D-7F05F1A92E7CQ36113467-3C5A9047-8B5D-4A1D-A666-C2BE17544AFBQ36323522-7FD291FA-383A-4512-8752-407DD4FC2D8AQ36351638-B1D28168-3CCE-4C92-9BE5-057419943BB9Q36609289-1A8E0EE8-E929-4DFD-A806-E18DACABDB4FQ36883052-66CAFFA2-6D07-497C-963B-EA714AC573D5Q37103359-023532F7-8944-4E75-9AFA-D69A71592725Q37174909-3509F535-1703-47B7-B5F9-A65E0AD2553EQ37852180-44DC468C-7BE2-4AA8-B665-EF2F194C0B27Q38155806-616B6935-2310-4FC8-9923-DD02F44FFCFEQ38589482-CFC24EE9-70C6-4ABF-981A-D64B6D0E5575Q39260620-143A5D18-8B6C-4DEF-84D1-B03CE4A28634Q41693925-27974CEE-07AF-4CD0-8CB6-997F179663C1Q42968242-73B21510-461C-49A8-A142-646C8C2B0EB9Q47680320-53782007-0EA2-4856-B386-7469F3870F6AQ48027529-AF47C610-BE01-499E-BDD7-911E2DF1A4C4Q48334514-820FD5A8-0661-4897-A61A-AD40390AF15E
P2860
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abnormal expression of glutama ...... y patients with schizophrenia.
@en
Abnormal expression of glutama ...... y patients with schizophrenia.
@nl
type
label
Abnormal expression of glutama ...... y patients with schizophrenia.
@en
Abnormal expression of glutama ...... y patients with schizophrenia.
@nl
prefLabel
Abnormal expression of glutama ...... y patients with schizophrenia.
@en
Abnormal expression of glutama ...... y patients with schizophrenia.
@nl
P2093
P2860
P1476
Abnormal expression of glutama ...... y patients with schizophrenia.
@en
P2093
Daya Gupta
Deborah Bauer
James H Meador-Woodruff
Robert E McCullumsmith
Vahram Harotunian
P2860
P304
P356
10.1016/J.SCHRES.2008.06.012
P407
P577
2008-08-03T00:00:00Z